000 | 01686 a2200493 4500 | ||
---|---|---|---|
005 | 20250517150026.0 | ||
264 | 0 | _c20170908 | |
008 | 201709s 0 0 eng d | ||
022 | _a1939-327X | ||
024 | 7 |
_a10.2337/db17-0058 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aSun, Emily W | |
245 | 0 | 0 |
_aMechanisms Controlling Glucose-Induced GLP-1 Secretion in Human Small Intestine. _h[electronic resource] |
260 |
_bDiabetes _c08 2017 |
||
300 |
_a2144-2149 p. _bdigital |
||
500 | _aPublication Type: Journal Article | ||
650 | 0 | 4 |
_aCalcium Channels _xphysiology |
650 | 0 | 4 | _aDose-Response Relationship, Drug |
650 | 0 | 4 |
_aDuodenum _xmetabolism |
650 | 0 | 4 |
_aGlucagon-Like Peptide 1 _xmetabolism |
650 | 0 | 4 |
_aGlucose _xadministration & dosage |
650 | 0 | 4 |
_aGlucose Transporter Type 2 _xphysiology |
650 | 0 | 4 |
_aGlutamates _xmetabolism |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aIleum _xmetabolism |
650 | 0 | 4 | _aInfusions, Parenteral |
650 | 0 | 4 |
_aMethylglucosides _xmetabolism |
650 | 0 | 4 |
_aMitochondria _xmetabolism |
650 | 0 | 4 |
_aPhlorhizin _xmetabolism |
650 | 0 | 4 |
_aSodium-Glucose Transporter 1 _xantagonists & inhibitors |
650 | 0 | 4 |
_aSweetening Agents _xadministration & dosage |
700 | 1 | _ade Fontgalland, Dayan | |
700 | 1 | _aRabbitt, Philippa | |
700 | 1 | _aHollington, Paul | |
700 | 1 | _aSposato, Luigi | |
700 | 1 | _aDue, Steven L | |
700 | 1 | _aWattchow, David A | |
700 | 1 | _aRayner, Christopher K | |
700 | 1 | _aDeane, Adam M | |
700 | 1 | _aYoung, Richard L | |
700 | 1 | _aKeating, Damien J | |
773 | 0 |
_tDiabetes _gvol. 66 _gno. 8 _gp. 2144-2149 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.2337/db17-0058 _zAvailable from publisher's website |
999 |
_c27057840 _d27057840 |